A new treatment option for raised seborrheic keratoses |
Journal Updates
eMediNexus Coverage from: 
A new treatment option for raised seborrheic keratoses
eMediNexus,  16 December 2017
Coronavirus Live Count Map India

remove_red_eye 1796 Views
Coronavirus Live Count Map World

#Dermatology

10 Read Comments                

The US Food and Drug Administration (FDA) has approved a high-concentration hydrogen peroxide topical solution (Eskata, Aclaris Therapeutics) for the treatment of raised seborrheic keratosis, which are noncancerous skin growths.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now